Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cryo Technique Enables Scientists to See Brain Tumor Cell Migration

By MedImaging International staff writers
Posted on 08 Sep 2011
For the first time, scientists can see pathways to stop a lethal brain cancer from spreading. More...
Researchers have imaged individual cancer cells and the pathways they move as the tumor metastasizes. The researchers used an innovative cryoimaging technique to obtain the first-time look at a mouse model of glioblastoma multiforme (GBM), an especially aggressive cancer that has no treatments to stop it from metastasizing.

The study’s findings were published September 1, 2011, in the journal Cancer Research. “We’re able to see things we couldn’t before, and we can use these images to understand how tumor cells invade and disperse,” said Susann M. Brady-Kalnay, a professor of molecular biology and microbiology at the Case Western Reserve School of Medicine (Cleveland, OH, USA), and senior author of the study. That data, in turn, can be used to help develop and assess the effectiveness of drugs and other therapies used to treat the cancer, she said.

To obtain the view, the scientists used a model that included four different cell lines of brain cancers at various stages of tumor development and dispersion. The cancer cells were modified with fluorescent markers and implanted in the model’s brain in collaboration with biomedical engineering Prof. James Basilion’s lab. The cryoimaging system, developed by Dr. David Wilson, also a professor of biomedical engineering at Case Western Reserve, disassembles the brain layer by layer and reassembles the model into a color three-dimensional (3D) digital image.

Utilizing software and algorithms designed by the researchers, the scientists are able to differentiate the main tumor mass, the blood vessels that feed the cancer and dispersing cells. The imaging system enables them to peer at single cells and see exactly where they are in the brain. The lead researchers, Susan Burden-Gulley, Mohammed Qutaish, and Kristin Sullivant, found that two cell lines, a human brain cancer LN229, and a rodent cancer CNS-1, best resemble the actions of GBM in human patients.

Reconstructions of models of those two lines enabled the researchers to examine the extent and patterns of cancer cell migration and dispersal from tumors along blood vessels and white matter tracts within the brain. The ability to generate such clear and detailed images, according to the researchers, will be instrumental when evaluating the effectiveness of drugs and other therapies designed to block dispersal of glioblastoma multiforme cells.

Related Links:
Case Western Reserve School of Medicine




Diagnostic Ultrasound System
DC-80A
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Pocket Fetal Doppler
CONTEC10C/CL
Multi-Use Ultrasound Table
Clinton
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.